Clinical Evidence


Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HD
Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis - Laville et al.
HDx therapy enabled by Theranova
Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration
HDx therapy enabled by Theranova
Rhabdomyolysis-Induced Acute Kidney Injury Treated with Medium Cut-Off Membrane: A Case Report.
HDx therapy enabled by Theranova
Role of expanded hemodialysis in COVID-19: a case report.
HDx therapy enabled by Theranova
Short-term clinical results when comparing expanded hemodialysis therapy versus online hemodiafiltration therapy
PD
Simultaneous Optimization of Ultrafiltration and Solute Transport in Automated Peritoneal Dialysis (APD) - Bergling K et al.
PD
Stakeholder Priorities for Remote Management in Peritoneal Dialysis - Subramanian L et al.
HDx therapy enabled by Theranova
Successful pregnancy in a hemodialysis patient with primary hyperoxaluria type 1
PD
Superiority of Icodextrin Compared with 4.25% Dextrose for Peritoneal Ultrafiltration - Finkelstein F, et al.
HDx therapy enabled by Theranova
Synergy of sodium thiosulphate treatment and expanded hemodialysis in the management of calciphylaxis? A case report
HDx therapy enabled by Theranova
Synergy of sodium thiosulphate treatment and expanded hemodialysis in the management of calciphylaxis? A case report
HDx therapy enabled by Theranova
Systematic review to compare the outcomes associated with the modalities of expanded hemodialysis (HDx) versus high-flux hemodialysis and/or hemodiafiltration (HDF) in patients with end-stage kidney disease (ESKD)

Vantive is a trademark of Vantive Health LLC or its affiliates.